United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $834,836,763.10
- April 17, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 28, 2014 | EVP | 5,000 | $92.07 | Sell | $460,350.00 | |
Aug. 28, 2014 | CEO | 7,014 | $92.46 | Sell | $648,514.44 | |
Aug. 21, 2014 | CEO | 9,640 | $93.13 | Sell | $897,773.20 | |
Aug. 21, 2014 | CFO | 10,000 | $93.75 | Sell | $937,500.00 | |
Aug. 15, 2014 | Director | 1,500 | $91.14 | Sell | $136,710.00 | |
Aug. 14, 2014 | CEO | 4,115 | $88.39 | Sell | $363,724.85 | |
Aug. 14, 2014 | EVP | 10,000 | $88.41 | Sell | $884,100.00 | |
Aug. 7, 2014 | Director | 5,000 | $88.23 | Sell | $441,150.00 | |
Aug. 7, 2014 | CFO | 10,000 | $86.44 | Sell | $864,400.00 | |
Aug. 7, 2014 | CEO | 4,115 | $88.40 | Sell | $363,766.00 | |
Aug. 1, 2014 | Director | 3,000 | $89.52 | Sell | $268,560.00 | |
Aug. 1, 2014 | COO | 10,000 | $89.88 | Sell | $898,800.00 | |
July 31, 2014 | CEO | 3,933 | $90.95 | Sell | $357,706.35 | |
July 29, 2014 | COO | 50,000 | $96.25 | Sell | $4,812,500.00 | |
July 25, 2014 | COO | 10,000 | $91.54 | Sell | $915,400.00 | |
July 24, 2014 | CEO | 9,228 | $93.15 | Sell | $859,588.20 | |
July 17, 2014 | CEO | 3,833 | $90.87 | Sell | $348,304.71 | |
July 17, 2014 | CFO | 10,000 | $89.74 | Sell | $897,400.00 | |
July 11, 2014 | COO | 10,000 | $93.06 | Sell | $930,600.00 | |
July 10, 2014 | CEO | 9,187 | $92.33 | Sell | $848,235.71 | |
July 3, 2014 | CFO | 10,000 | $90.58 | Sell | $905,800.00 | |
July 3, 2014 | CEO | 3,833 | $91.37 | Sell | $350,221.21 | |
July 3, 2014 | Director | 1,500 | $91.62 | Sell | $137,430.00 | |
June 26, 2014 | CEO | 3,833 | $87.23 | Sell | $334,352.59 | |
June 20, 2014 | COO | 10,000 | $87.00 | Sell | $870,000.00 | |
June 19, 2014 | EVP | 2,000 | $85.67 | Sell | $171,340.00 | |
June 19, 2014 | CEO | 3,833 | $85.68 | Sell | $328,411.44 | |
June 19, 2014 | CFO | 10,000 | $87.02 | Sell | $870,200.00 | |
June 12, 2014 | CEO | 9,066 | $98.22 | Sell | $890,462.52 | |
June 10, 2014 | COO | 10,000 | $96.29 | Sell | $962,900.00 | |
June 9, 2014 | COO | 10,000 | $96.32 | Sell | $963,200.00 | |
June 5, 2014 | Director | 1,500 | $96.48 | Sell | $144,720.00 | |
June 5, 2014 | EVP | 6,000 | $96.50 | Sell | $579,000.00 | |
June 5, 2014 | CEO | 9,066 | $96.46 | Sell | $874,506.36 | |
June 3, 2014 | COO | 10,000 | $95.00 | Sell | $950,000.00 | |
May 29, 2014 | CEO | 9,066 | $95.27 | Sell | $863,717.82 | |
May 27, 2014 | COO | 10,000 | $99.14 | Sell | $991,400.00 | |
May 22, 2014 | Director | 30,000 | $101.46 | Sell | $3,043,800.00 | |
May 22, 2014 | CEO | 9,066 | $101.35 | Sell | $918,839.10 | |
May 20, 2014 | COO | 10,000 | $99.91 | Sell | $999,100.00 | |
May 16, 2014 | COO | 10,000 | $100.00 | Sell | $1,000,000.00 | |
May 15, 2014 | CFO | 10,000 | $101.49 | Sell | $1,014,900.00 | |
May 15, 2014 | CEO | 9,066 | $100.88 | Sell | $914,578.08 | |
May 15, 2014 | EVP | 6,000 | $100.86 | Sell | $605,160.00 | |
May 13, 2014 | COO | 10,000 | $105.53 | Sell | $1,055,300.00 | |
May 8, 2014 | Director | 5,000 | $107.17 | Sell | $535,850.00 | |
May 8, 2014 | CEO | 9,066 | $107.83 | Sell | $977,586.78 | |
May 6, 2014 | COO | 10,000 | $106.50 | Sell | $1,065,000.00 | |
May 2, 2014 | COO | 10,000 | $102.00 | Sell | $1,020,000.00 | |
May 1, 2014 | Director | 1,500 | $99.30 | Sell | $148,950.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.